Opko Health Inc OPK

NAS: OPK | ISIN: US68375N1037 14/11/2024

1,620 USD (+1,25%)

(+1,25%) 14/11/2024

Grafiek Opko Health Inc

Grafiek Opko Health Inc

1 dag1d 1,25%
1 week1w 6,58%
1 maand1m 10,20%
3 maanden3m 2,53%
6 maanden6m 20,00%
1 jaar1j 14,08%
5 jaar5j 8,72%

Opko Health Inc in het nieuws

Toon enkel gratis nieuws

2 juli 2024 · NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner · Persbericht

28 maart 2024 · Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business · Persbericht

28 februari 2024 · NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st · Persbericht

5 februari 2024 · NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China · Persbericht

7 november 2023 · BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ · Persbericht

29 september 2023 · Thinking about buying stock in Blue Apron Holdings, OceanPal, OPKO Health, Bionomics, or Aytu Biopharma? · Persbericht

9 februari 2023 · BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings · Persbericht

16 maart 2022 · GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions · Persbericht

1 maart 2022 · Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease · Persbericht

29 november 2021 · BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S. · Persbericht

Profiel Opko Health Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.opko.com

Hoofdzetel: Miami, Florida Verenigde Staten

CEO: Phillip Frost

Werknemers: 339

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe